PI
DNA icon

PFG Investments’s Ginkgo Bioworks DNA Stock Holding History

PFG Investments’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,900
Closed -$186K – 1040
2024
Q4 		$186K Sell
18,900
-170,130
-90% -$1.46M 0.01% 909
2024
Q3 		$1.54M Buy
+189,030
New +$1.89M 0.1% 201

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

PFG Investments's DNA Position: Q1 2025 in Review

PFG Investments sold out of Ginkgo Bioworks (DNA) in Q1 2025, closing a stake of 18,900 shares — an estimated $186K sold.

PFG Investments first reported a position in DNA in Q3 2024 and held it in 2 quarters. The position peaked at $1.54M in Q3 2024. 165 funds tracked by Wall St. Rank hold DNA as of Q1 2025.

  • PFG Investments reported no remaining Ginkgo Bioworks position as of Q1 2025 after selling out during the quarter.
  • PFG Investments sold 18,900 Ginkgo Bioworks shares in Q1 2025, an estimated $186K.
  • PFG Investments first reported a position in Ginkgo Bioworks in Q3 2024 and held it in 2 quarters.
  • PFG Investments's Ginkgo Bioworks position peaked at $1.54M in Q3 2024.
  • 165 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2025.

Based on PFG Investments's 13F filing for Q1 2025, filed 22 Apr 2025.